Latest Breaking News On - Michel nuta - Page 1 : vimarsana.com

Theraclion Achieves an Important Milestone on the Road to the U S Market: First Patients Treated With SONOVEIN as Part of the FDA-approved Pivotal Study

Theraclion Achieves an Important Milestone on the Road to the U S Market: First Patients Treated With SONOVEIN as Part of the FDA-approved Pivotal Study
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesNew jerseyMichel nutaSteve eliasMartin deterreIndiens wirtschaftIhre chancenFood drug administrationAmerican college of surgeonsRegulatory newsVein diseaseAmerican boardLymphatic medicineAmerican collegeChief executive officer

FDA Approval for Pivotal Varicose Veins Study With Theraclion s SONOVEIN

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, announces today that

New jerseyUnited statesFrance generalYann duchesneMichel nutaSteven eliasUs food drug administrationAmerican college of surgeonsRegulatory newsDrug administrationInvestigational device exemptionChief medical officerVice president veinsExecutive chairmanUnited statedVein disease

FDA Approval for Pivotal Varicose Veins Study With Theraclion s SONOVEIN®

FDA Approval for Pivotal Varicose Veins Study With Theraclion s SONOVEIN®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesFrance generalYann duchesneSteven eliasMichel nutaUs food drug administrationAmerican college of surgeonsWall streetDrug administrationInvestigational device exemptionChief medical officerVice president veinsExecutive chairmanUnited statedVein disease

Theraclion Announces Results of First US Trial

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, announces today the

United statesFrance generalNew jerseyAntonios gasparisMichel nutaSteve eliasNicos labropoulosFood drug administrationRegulatory newsChief medical officerVeins vice president dr michel nutaFrench medtechIntensity focused ultrasoundEuronext growth parisOperating officerProfi marcel torney

THERACLION: Last Patient of First SONOVEIN® US Study Has Been Treated

THERACLION: Last Patient of First SONOVEIN® US Study Has Been Treated
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew orleansFrance generalAntonios gasparisMichel nutaSteve eliasNicos labropoulosFood drug administrationAmerican vein lymphatic societyDrug administrationAmerican veinLymphatic societyAnnual congressChief medical officerHigh intensity focused ultrasoundEuronext growth paris